Medeon Biodesign, Inc. (TPEX:6499)
Taiwan
· Delayed Price · Currency is TWD 44.65
+0.95 (2.17%)
Apr 2, 2025, 1:30 PM CST
Medeon Biodesign Revenue
In the year 2024, Medeon Biodesign had annual revenue of 292.81M TWD with 49.19% growth. Medeon Biodesign had revenue of 77.35M in the quarter ending December 31, 2024, with 39.43% growth.
Revenue
292.81M
Revenue Growth
+49.19%
P/S Ratio
14.05
Revenue / Employee
7.51M
Employees
39
Market Cap
4.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 292.81M | 96.55M | 49.19% |
| Dec 31, 2023 | 196.26M | -102.05M | -34.21% |
| Dec 31, 2022 | 298.32M | 229.36M | 332.61% |
| Dec 31, 2021 | 68.96M | -54.10M | -43.96% |
| Dec 31, 2020 | 123.06M | -330.71M | -72.88% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 9.73B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 18.58B |
| Oneness Biotech | 117.93M |
| Lumosa Therapeutics | 39.15M |
| Pegavision | 6.82B |
| Polaris Group | 107.00M |